There were 18 (45%) patients with CADM in patients with anti-MDA5-positive DM, and 15 (36%) patients with CADM in patients with anti-MDA5-negative DM (p > 0.05). Here, IFIH1 is linked to clinically amyopathic dermatomyositis.